随着健康意识的提升,“减重”越来越为全民所关注,并逐渐发展成一个庞大的市场,规模逐年上升。为此,国内外多家药企纷纷加大布局,加快减重药物研发,抢占更多的市场份额。 新减肥药上市加剧竞争 6月27日,国家药品监督管理局批准信达生物申报的1类创新药玛仕度肽注射液上市,用于成人肥胖或超重患者的长期体重控制。7月3日,玛仕度肽在北京大学人民医院开出全国首张处方。 据了解,玛仕度肽是全球首个获批的胰...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.